Why Do People (Still) Go Blind from Glaucoma?
作者信息
Susanna Remo, De Moraes Carlos Gustavo, Cioffi George A, Ritch Robert
机构信息
Department of Ophthalmology, University of Sao Paulo School of Medicine, Sao Paulo, SP, Brazil.
Department of Ophthalmology, Columbia University Medical Center, New York, NY, USA.
出版信息
Transl Vis Sci Technol. 2015 Mar 9;4(2):1. doi: 10.1167/tvst.4.2.1. eCollection 2015 Mar.
Abstract
摘要
相似文献
1
Why Do People (Still) Go Blind from Glaucoma?
Transl Vis Sci Technol. 2015 Mar 9;4(2):1. doi: 10.1167/tvst.4.2.1. eCollection 2015 Mar.
2
Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision.
Am J Ophthalmol. 2002 Jun;133(6):764-72. doi: 10.1016/s0002-9394(02)01403-4.
3
Lifetime visual disability in open-angle glaucoma and ocular hypertension.
J Glaucoma. 2007 May;16(3):313-9. doi: 10.1097/IJG.0b013e318033500f.
4
Factors associated with lifetime risk of open-angle glaucoma blindness.
Acta Ophthalmol. 2014 Aug;92(5):421-5. doi: 10.1111/aos.12203. Epub 2013 Jul 10.
5
Ethnicity and Deprivation are Associated With Blindness Among Adults With Primary Glaucoma in Nigeria: Results From the Nigeria National Blindness and Visual Impairment Survey.
J Glaucoma. 2016 Oct;25(10):e861-e872. doi: 10.1097/IJG.0000000000000487.
6
A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey.
BMC Ophthalmol. 2015 Dec 12;15:176. doi: 10.1186/s12886-015-0160-6.
7
A Systematic Review of End-of-Life Visual Impairment in Open-Angle Glaucoma: An Epidemiological Autopsy.
J Glaucoma. 2016 Jul;25(7):623-8. doi: 10.1097/IJG.0000000000000389.
8
Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma.
Am J Ophthalmol. 2001 Jul;132(1):47-56. doi: 10.1016/s0002-9394(01)00912-6.
9
PITUITARY TUMORS AND INTRAOCULAR PRESSURE.
Am J Ophthalmol. 1964 Feb;57:267-9. doi: 10.1016/0002-9394(64)91833-1.
10
Lifetime risk of blindness in open-angle glaucoma.
Am J Ophthalmol. 2013 Oct;156(4):724-30. doi: 10.1016/j.ajo.2013.05.027. Epub 2013 Aug 7.
引用本文的文献
1
Prevalence of glaucoma in Africa: A systematic review and Bayesian meta-analysis.
PLoS One. 2025 Aug 14;20(8):e0330567. doi: 10.1371/journal.pone.0330567. eCollection 2025.
2
Intelligent screening of narrow anterior chamber angle based on portable slit lamp.
NPJ Digit Med. 2025 Jul 17;8(1):449. doi: 10.1038/s41746-025-01853-2.
3
Real-Life Effectiveness and Safety of Selective Laser Trabeculoplasty as Primary, Adjunctive, and Substitutive Therapy.
Turk J Ophthalmol. 2025 Jun 25;55(3):132-140. doi: 10.4274/tjo.galenos.2025.75570.
4
Diagnostic Performance of a Handheld Electroretinography Test for Glaucoma.
Ophthalmol Sci. 2025 Feb 13;5(4):100739. doi: 10.1016/j.xops.2025.100739. eCollection 2025 Jul-Aug.
5
Longitudinal Change in Retinal Nerve Fiber Layer Thickness and Intraocular Pressure in Young Adults.
Transl Vis Sci Technol. 2025 Apr 1;14(4):3. doi: 10.1167/tvst.14.4.3.
6
Multimodal Artificial Intelligence Models Predicting Glaucoma Progression Using Electronic Health Records and Retinal Nerve Fiber Layer Scans.
Transl Vis Sci Technol. 2025 Mar 3;14(3):27. doi: 10.1167/tvst.14.3.27.
7
Does Age Modify the Relation Between Genetic Predisposition to Glaucoma and Various Glaucoma Traits in the UK Biobank?
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):57. doi: 10.1167/iovs.66.2.57.
8
Early safety and efficacy outcomes of the PAUL glaucoma implant in a Spanish population: A retrospective study.
Saudi J Ophthalmol. 2024 Nov 18;38(4):368-373. doi: 10.4103/sjopt.sjopt_164_24. eCollection 2024 Oct-Dec.
9
Validation of a Novel Low-Cost Glaucoma Risk Calculator for Community-Based Screening in High-Risk Populations.
Clin Ophthalmol. 2025 Feb 3;19:357-369. doi: 10.2147/OPTH.S500509. eCollection 2025.
10
OCT-based diagnosis of glaucoma and glaucoma stages using explainable machine learning.
Sci Rep. 2025 Jan 28;15(1):3592. doi: 10.1038/s41598-025-87219-w.
本文引用的文献
1
Visual fields and OCT role in diagnosis of glaucoma.
Optom Vis Sci. 2014 Nov;91(11):1312-9. doi: 10.1097/OPX.0000000000000394.
2
Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles.
Invest Ophthalmol Vis Sci. 2014 Sep 11;55(11):7387-97. doi: 10.1167/iovs.14-14651.
3
Burden of undetected and untreated glaucoma in the United States.
Am J Ophthalmol. 2014 Dec;158(6):1121-1129.e1. doi: 10.1016/j.ajo.2014.08.023. Epub 2014 Aug 22.
4
The pathophysiology and treatment of glaucoma: a review.
JAMA. 2014 May 14;311(18):1901-11. doi: 10.1001/jama.2014.3192.
5
Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota.
Ophthalmology. 2014 Jan;121(1):134-141. doi: 10.1016/j.ophtha.2013.09.003. Epub 2013 Oct 25.
6
Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation.
PLoS One. 2014 Apr 30;9(4):e95461. doi: 10.1371/journal.pone.0095461. eCollection 2014.
7
A comparative effectiveness analysis of visual field outcomes after projected glaucoma screening using SD-OCT in African American communities.
Invest Ophthalmol Vis Sci. 2014 May 1;55(6):3491-500. doi: 10.1167/iovs.14-14014.
8
Glaucomatous optic neuropathy evaluation project: factors associated with underestimation of glaucoma likelihood.
JAMA Ophthalmol. 2014 May;132(5):560-6. doi: 10.1001/jamaophthalmol.2014.96.
9
Sustained drug delivery in glaucoma.
Curr Opin Ophthalmol. 2014 Mar;25(2):112-7. doi: 10.1097/ICU.0000000000000031.
10
Baseline prognostic factors predict rapid visual field deterioration in glaucoma.
Invest Ophthalmol Vis Sci. 2014 Apr 7;55(4):2228-36. doi: 10.1167/iovs.13-12261.
Zotero 插件